Annotated Medicine and Device Lists


Losartan

This medicine is present in:

List Section Observation
Colombia. "Listado de Medicamentos del Plan de Beneficios en Salud con Cargo a la UPC" 2016 Listado de Medicamentos del Plan de Beneficios en Salud con cargo a la UPC Others observations:
INCLUYE TODAS LAS CONCENTRACIONES Y FORMAS FARMACÉUTICAS
Argentina. FTN COMRA. Confederacion Medica de la Rep. Argentina. 2018 02.03. FARMACOS ANTIHIPERTENSIVOS No observations

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines (2021) 12.3. Antihypertensive medicines This medicine has the best evidence for effectiveness and safety.
Guyana. Essential Medicines List. 2020-2021 Reserved for specialist use No observations
Organisation of Eastern Caribbean States. Medical Products List. 2019-2021 24:08 Anti-hypertensive agents No observations
Belize. National Drug Formulary 12.03 Antihypertensive medicines No observations

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines (2021) 12.3. Antihypertensive medicines No observations
WHO Model List of Essential Medicines (2021) 12.4. Medicines used in heart failure This medicine has the best evidence for effectiveness and safety.
Organisation of Eastern Caribbean States. Medical Products List. 2019-2021 24:08 Anti-hypertensive agents No observations
Haiti. National List of Essential Medicines 12.03 Anti-hypertensives No observations
Haiti. National List of Essential Medicines 12.04 Medicines for heart failure No observations
Barbados. Barbados National Drug Formulary (BNDF) 24.32.08 Angiotensin II Receptor Antagonist No observations
Bahamas. Drug Formulary 02. CARDIOVASCULAR DRUGS No observations
Cayman Islands Health Services Authority Pharmacy Drug Formulary 02.05.04.02 Angiotensin II Receptor Antagonists No observations

This medicine is present in:

List Section Observation
Peru 12.3 Anti-Hypertensives No observations
Trinidad and Tobago. Pharmaceutical Ven Listing 2019. Ministry of Health. Cvs Angiotensin II Antagonists No observations
Mexico. Cuadro Basico de Medicamentos - 2017 03. CARDIOLOGIA No observations
Mexico. Cuadro Basico de Medicamentos - 2017 03. CARDIOLOGIA No observations
Brasil. Relação Nacional de Medicamentos Essenciais. 2020 C. APARELHO CARDIOVASCULAR No observations
Chile. Formulario Nacional de Medicamentos. 2005 11.03. ANTIHIPERTENSIVOS No observations

This medicine is present in:

List Section Observation
Bolivia. Lista Nacional de Medicamentos Esenciales 2018-2020 09 AGENTES QUE ACTÚAN SOBRE EL SISTEMA RENINA-ANGIOTENSINA No observations
Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015 01.06 ANGIOTENSIN II RECEPTOR ANTAGONIST No observations
Paraguay. Lista de Medicamentos Esenciales. 2009 09. AGENTES QUE ACTÚAN SOBRE EL SISTEMA RENINA-ANGIOTENSINA No observations
WHO Model List of Essential Medicines (2021) 12.4. Medicines used in heart failure This medicine has the best evidence for effectiveness and safety.
Suriname. NGK-C-011 12.3 Antihypertensives No observations
Suriname. NGK-C-011 12.4 Medicines for Heart Failure No observations
Suriname. NGK-C-011 29.2 Other Special Essential Medicines No observations
Haiti. National List of Essential Medicines 12.03 Anti-hypertensives No observations
Haiti. National List of Essential Medicines 12.04 Medicines for heart failure No observations
Barbados. Barbados National Drug Formulary (BNDF) 24.32.08 Angiotensin II Receptor Antagonist No observations
Bahamas. Drug Formulary 02. CARDIOVASCULAR DRUGS No observations
Cayman Islands Health Services Authority Pharmacy Drug Formulary 02.05.04.02 Angiotensin II Receptor Antagonists No observations

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines (2021) 12.3. Antihypertensive medicines This medicine has the best evidence for effectiveness and safety.
WHO Model List of Essential Medicines (2021) 12.4. Medicines used in heart failure This medicine has the best evidence for effectiveness and safety.
Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015 01.06 ANGIOTENSIN II RECEPTOR ANTAGONIST No observations
Guyana. Essential Medicines List. 2020-2021 Reserved for specialist use No observations
Organisation of Eastern Caribbean States. Medical Products List. 2019-2021 24:08 Anti-hypertensive agents No observations
Haiti. National List of Essential Medicines 12.03 Anti-hypertensives No observations
Haiti. National List of Essential Medicines 12.04 Medicines for heart failure No observations
Bahamas. Drug Formulary 02. CARDIOVASCULAR DRUGS No observations
Belize. National Drug Formulary 12.03 Antihypertensive medicines No observations
Cayman Islands Health Services Authority Pharmacy Drug Formulary 02.05.04.02 Angiotensin II Receptor Antagonists No observations

Information Resources: Losartan

Loading ...
Loading ...
Loading ...
No information available